Huiting Wei

674 total citations
12 papers, 524 citations indexed

About

Huiting Wei is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Huiting Wei has authored 12 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Surgery. Recurrent topics in Huiting Wei's work include Cell death mechanisms and regulation (2 papers), Escherichia coli research studies (2 papers) and interferon and immune responses (1 paper). Huiting Wei is often cited by papers focused on Cell death mechanisms and regulation (2 papers), Escherichia coli research studies (2 papers) and interferon and immune responses (1 paper). Huiting Wei collaborates with scholars based in China, United States and Poland. Huiting Wei's co-authors include Junying Yuan, Zhi Yao, Shao‐Cong Sun, Ying Li, Huyan Meng, Xingyan Li, Kangyun Dong, Huibing Wang, Kezhou Zhu and Adnan K. Mookhtiar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Frontiers in Immunology and Frontiers in Microbiology.

In The Last Decade

Huiting Wei

12 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huiting Wei China 8 330 211 148 60 51 12 524
Qiang Feng China 13 360 1.1× 170 0.8× 106 0.7× 86 1.4× 34 0.7× 51 571
Rihao Qu United States 11 351 1.1× 81 0.4× 199 1.3× 137 2.3× 81 1.6× 23 661
Dongyao Wang China 11 216 0.7× 96 0.5× 150 1.0× 110 1.8× 89 1.7× 32 500
Xiaoling Yu China 13 214 0.6× 100 0.5× 184 1.2× 45 0.8× 53 1.0× 36 507
Michael S. Hwang United States 10 165 0.5× 138 0.7× 90 0.6× 66 1.1× 32 0.6× 19 566
Xue-Chun Lu China 12 233 0.7× 182 0.9× 209 1.4× 39 0.7× 45 0.9× 39 560
Vassilios Atsaves United States 13 373 1.1× 209 1.0× 130 0.9× 116 1.9× 46 0.9× 19 619
Anjaiah Srirangam United States 9 189 0.6× 135 0.6× 44 0.3× 64 1.1× 69 1.4× 13 410
José Luis Linares France 4 318 1.0× 208 1.0× 183 1.2× 48 0.8× 26 0.5× 4 629
Kazuhiko Hanashiro Japan 10 231 0.7× 165 0.8× 46 0.3× 43 0.7× 40 0.8× 39 427

Countries citing papers authored by Huiting Wei

Since Specialization
Citations

This map shows the geographic impact of Huiting Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiting Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiting Wei more than expected).

Fields of papers citing papers by Huiting Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiting Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiting Wei. The network helps show where Huiting Wei may publish in the future.

Co-authorship network of co-authors of Huiting Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Huiting Wei. A scholar is included among the top collaborators of Huiting Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiting Wei. Huiting Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Zhang, Yaodan, et al.. (2024). Oridonin Attenuates Diabetes‑induced Renal Fibrosis via the Inhibition of TXNIP/NLRP3 and NF‑κB Pathways by Activating PPARγ in Rats. Experimental and Clinical Endocrinology & Diabetes. 132(10). 536–544. 1 indexed citations
3.
Wei, Huiting, et al.. (2022). ShenKang Injection Attenuates Renal Fibrosis by Inhibiting EMT and Regulating the Wnt/β-Catenin Pathway. Evidence-based Complementary and Alternative Medicine. 2022. 1–15. 15 indexed citations
4.
5.
Wei, Huiting, et al.. (2020). Association of FcγRIIA‐R/H131 polymorphism and systemic lupus erythematosus lupus nephritis risk: A meta‐analysis. International Journal of Rheumatic Diseases. 23(7). 853–867. 3 indexed citations
6.
Wang, Yu, Bing Shan, Yaosi Liang, Huiting Wei, & Junying Yuan. (2018). Parkin regulates NF-κB by mediating site-specific ubiquitination of RIPK1. Cell Death and Disease. 9(7). 732–732. 41 indexed citations
7.
Wang, Huibing, Huyan Meng, Xingyan Li, et al.. (2017). PELI1 functions as a dual modulator of necroptosis and apoptosis by regulating ubiquitination of RIPK1 and mRNA levels of c-FLIP. Proceedings of the National Academy of Sciences. 114(45). 11944–11949. 94 indexed citations
8.
Zhang, Zhi‐Song, Huiting Wei, Jingyu Wang, et al.. (2017). Cytotoxic necrotizing factor 1 promotes prostate cancer progression through activating the Cdc42–PAK1 axis. The Journal of Pathology. 243(2). 208–219. 39 indexed citations
9.
Liu, Ran, Huiting Wei, Peng Gao, et al.. (2017). CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis. Oncotarget. 8(24). 39021–39032. 72 indexed citations
10.
Ren, Yi, Wei Wang, Yi Wang, et al.. (2016). A High-resolution Typing Assay for Uropathogenic Escherichia coli Based on Fimbrial Diversity. Frontiers in Microbiology. 7. 623–623. 13 indexed citations
11.
Wei, Huiting, et al.. (2016). Functions of PARylation in DNA Damage Repair Pathways. Genomics Proteomics & Bioinformatics. 14(3). 131–139. 228 indexed citations
12.
Fu, Zheng, Li Ren, Huiting Wei, et al.. (2013). Effects of Tyroserleutide on phosphatidylinositol 3′-kinase/AKT pathway in human hepatocellular carcinoma cell. Journal of drug targeting. 22(2). 146–155. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026